Intestinal tuberculosis in a patient on infliximab treatment.
Karagiannis
Stephanos
S
Department of Gastroenterology, Faculty of Nursing, Athens University, General Hospital of Athens Helena Venizelou, Athens, Greece.
Papaioannou
Dimitrios
D
Goulas
Spyros
S
Psilopoulos
Dimitrios
D
Mavrogiannis
Christos
C
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001707:Biopsy, Needle; D003108:Colonic Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003113:Colonoscopy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D007150:Immunohistochemistry; D000069285:Infliximab; D007413:Intestinal Mucosa / Q000473:pathology; D018570:Risk Assessment; D016896:Treatment Outcome; D014385:Tuberculosis, Gastrointestinal / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology
D000911:Antibodies, Monoclonal; D000995:Antitubercular Agents; D000069285:Infliximab